ஹார்வர்ட் லாங்வுட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IQX Limited (NSX:IQX) Progress of Clinical Programs    Progress of Clinical ProgramsSydney, April 29, 2021 AEST (ABN Newswire) - iQX Limited (iQX Ltd) ( NSX:IQX) would like to announce that Life Science Biosensor Diagnostics Pty Ltd (LSBD) in which iQX Ltd holds a 19% equity position, has received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a clinical validation study to test patient samples from a COVID-19 repository. The study follows a partnership with the Wyss Institute for Biologically Inspired Engineering at Harvard University (Wyss Institute), through Life Science Biosensor Diagnostics Pty Ltd subsidiary, GBS Inc. ( Nasdaq:GBS), a Delaware corporation, to develop a novel diagnostic SARS-CoV-2 test.

New yorkUnited statesNew south walesUnited kingdomCharles riverJonathan sesslerGeorge syrmalisHarvard longwoodHarvard university wyss instituteJohns hopkins universityBloomberg school of public healthHoldings incBiosensx north america incMd anderson cancer centerUt dell medical schoolLife science biosensor diagnostics pty ltd